from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2431c/PE25

LFCtreatmentdescriptionclass of inhibitor

1.538

Amikacinug/mL Amikacintranslation

1.692

Cap5-10ug/mL Capreomycintranslation

1.964

Rox10-50 ug/mL Roxithromycintranslation

0.584

SM2-5 ug/mL Streptomycintranslation

2.319

Tet5-10 ug/mL Tetracyclinetranslation

0.048

Rif0.2-5ug/mL Rifampicintranscription

1.843

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.498

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.289

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.208

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.015

Clofazimine10-13 ug/mL Clofaziminerespiration

0.573

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.686

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.387

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.604

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.410

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.065

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.144

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.203

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.535

KCN5-20 ug/mL Potassium cyaniderespiration

0.340

NaN30.2-2 mM Sodium aziderespiration

0.039

Nigericin50 uM Nigericinrespiration

0.287

TRC10-150 ug/mL Triclosanrespiration

0.835

TRZ10-25 ug/mL Thioridazinerespiration

0.087

Valinomycin0.5-10 uM Valinomycinrespiration

0.392

ZnSO42 mM ZnSO4respiration

0.063

menadione6-10 ug/mL Menadionerespiration

-0.932

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.190

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.929

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.070

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.228

NRP_1Non-replicating persistence stage 1dosRassociated

-0.064

Amp0.2mg/mL AmpicillincellWall

0.728

Cephalexin20-100 ug/mL CephalexincellWall

0.547

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.692

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.096

EMB10-20 ug/mL EthambutolcellWall

1.121

Eta12-40 ug/mL EthionamidecellWall

1.345

INH0.2-0.4 ug/mL IsoniazidcellWall

0.436

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.676

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.372

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.908

BZA0.12 mg/mL BenzamidearomaticAmides

-0.862

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.637

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.048

H2O24 mM hydrogen peroxideDNAdamaging

1.126

Levo10 ug/mL LevofloxacinDNAdamaging

-0.699

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.563

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.729

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.257

UVUV-irradiationDNAdamaging

1.084

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.217

Antimycin12.5-50 ug/mL Antimycin A?

-0.088

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.732

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.900

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.894

PA8240.2-2 ug/mL PA-824?

0.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.344

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.004

Verapamil50 uM Verapamil?

0.249

mercaptoethanol2 mM 2-Mercaptoethanol?

0.666

methoxatin10-20 ug/mL Methoxatin?